Hematology/Oncology

Top Story

Limited treatment safe, successful for pediatric patients with lymphocyte-predominant Hodgkin lymphoma

May 27, 2016

A majority of highly selected pediatric patients with lymphocyte-predominant Hodgkin lymphoma may be successfully treated with surgery alone, according to study results from the Children’s Oncology Group.

Patients treated with a less intensive chemotherapy regimen experienced excellent EFS outcomes, with the majority avoiding radiation therapy, results showed.

In the Journals

Surgeon’s proficiency in esophagectomy affects short- and long-term cancer outcomes

May 26, 2016
Undergoing esophagectomy with a surgeon who had performed at least 15 surgeries reduced short-term mortality among patients with esophageal cancer, according to results…
Meeting News Coverage

Top Takeaways from ASH: Benefits, drawbacks of Factor VIII products require discussion with patients

May 26, 2016
The multicenter, randomized Survey of Inhibitors in Plasma-Product Exposed Toddlers, or SIPPET study, presented at the ASH Annual Meeting and Exposition, which…
FDA News

FDA approves Afstyla to treat patients with hemophilia A

May 26, 2016
The FDA approved antihemophilic factor (recombinant), single chain to treat adults and children with hemophilia A.Antihemophilic factor (recombinant), single chain…
Ask the Experts

What is a cyst?

May 26, 2016
A cyst is a closed sac with a defined membrane and division on the nearby tissue. Cysts may contain fluid, air or semi-solid material. There are various types of…
More News Headlines »
CME

The Patient with Non-Small Cell Lung Cancer

No commercial support for this activity.

The management of non-small cell lung cancer (NSCLC) has evolved in the past decade, as advances are made in diagnosis…
More »
Video
At Issue

VIDEO: Emerging data on checkpoint blockades suggest potential ‘cure’ for certain tumors, not all cancer

May 16, 2016
More »
Featured
AACR Annual Meeting

AACR Annual Meeting

CME Video

Optimizing the Management of Metastatic Melanoma: Clinical Insights for Selecting First-line Therapy

This activity is supported by an independent educational grant from Merck & Co., Inc.

The incidence of melanoma is continuing to increase worldwide. In recent years, the treatment landscape for this…
More »
Current Issues
View the Current Issue
HemOnc Today